Stock·NASDAQ·Communication Services
Comcast Corp (CMCSA)
- Market cap
- $82.45B
- P/E
- 7.32
- Dividend yield
- 5.68%
- Street target
- $27.75median of 27 analysts
- 52-week range
- $20.48 $32.86
CMCSA stock forecast today
Where CMCSA stands today, and what CleaRank Financial AI makes of it.
CMCSA at a glance
Comcast Corp (CMCSA): Hold, 51/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($23.40 and $26.08).
- Earnings CMCSA beat estimates in 6 of its last 6 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $2.3M and made no open-market purchases over the last 18 months.
- Valuation P/E of 7.3 against 23.3 for the Communication Services sector: a discount to peers (-69%).
Figures as of October 30, 2026.
CleaRank Financial AI
Comcast Corp (CMCSA) carries a CleaRank rating of Hold and a model score of 51/100.
Valuation lifts the score the most. The P/E of 7.32 is 68.6% below the sector median P/E, marking a discount to peers, and the P/S of 0.67 is 73.2% below the sector median P/S. The trend holds the score back the most: the price sits 10.96% below its 200-day average and 0.76% below its 50-day average, and the 50-day average is 10.28% below the 200-day. The 50-day average is at $23.40 and the 200-day at $26.08. Across the past year the price fell 9.31%.
Only on CleaRank
Figures we compute ourselves from CMCSA's own price, earnings and insider-filing history. Tap one to see it in context.
CMCSA stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price below its 50-day average ›
The price of $23.22 is 0.8% below the 50-day simple moving average of $23.40.Price below its 200-day average ›
The price is 11.0% below the 200-day simple moving average of $26.08.50-day average below the 200-day ›
The 50-day average ($23.40) is 10.3% below the 200-day average ($26.08), the arrangement of a falling longer-term trend.In the lower half of its 52-week range ›
The price sits at 22% of its 52-week range, between $20.48 and $32.86.
CMCSA share price
Pick a period: each tab shows how far CMCSA has moved over it, to the last close.
Today's trading
Where CMCSA sits inside today's range and its 52-week range.
CMCSA fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 7.32 is 68.6% below the Communication Services median of 23.3.P/S below the sector median ›
The price-to-sales ratio of 0.67 is 73.3% below the sector median of 2.5.Profitable over the last 12 months ›
Net income over the last 12 months was $11.3B on revenue of $123.0B, a net margin of 9.2%.Beat estimates in most recent reports ›
CMCSA beat the EPS estimate in 6 of its last 6 reports.Pays a dividend ›
The trailing dividend yield is 5.68%, or $1.32 a share a year.
Key statistics
The headline figures for CMCSA.
As of October 30, 2026, CMCSA trades at $23.22, with a market value of $82.45B, a P/E ratio of 7.32 and a dividend yield of 5.68%.
What the numbers say
CleaRank Financial AI's reading of CMCSA's valuation, growth and risks.
Comcast Corp (CMCSA) trades at 7.32 times trailing earnings, which places its P/E 68.6% below the Communication Services median of 23.3. The peer comparison on this page calls that a discount to peers. On sales, the P/S of 0.67 is 73.2% below the sector median of 2.5. For context, the company's market value is $82.5B and its trailing earnings are $3.16 per share.
The company converts sales into profit at a net margin of 9.20% and an operating margin of 18.16%. Its return on equity of 11.43% sits below the sector median of 15.8%. Debt-to-equity is 0.94, and the trailing dividend yield is 5.68%, or $1.32 a share per year.
CMCSA reported EPS of $1.07 in its latest quarterly report on October 22, 2026, against the $0.99 that analysts had expected. That beat the estimate by 8.08%. Still, the share price slipped 0.66% in the first session after the report.
CMCSA has beaten the EPS estimate in all 6 of its recent reports, but beats have not guaranteed gains: the stock fell the next day after 3 of them. Of the 3 reports before the latest, the largest reaction came after the April 23, 2026 report, which beat the estimate by 8.22% while the stock fell 12.90%. The consensus EPS estimate stands at $3.50 for this fiscal year and $3.54 for next, a decline of 18.9% for the current year.
CMCSA typically moves about 1.85% in a day, and its beta against the S&P 500 is 0.67. The price staying under both moving averages keeps the downtrend a live risk. The stock is 29.34% below its 52-week high of $32.86. Insiders sold $2.3M of stock over the last 18 months and made no open-market purchases. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than buying.
CMCSA against the Communication Services sector
How CMCSA compares with the median Communication Services stock CleaRank tracks.
Price to earnings vs sector: CMCSA trades at a notable discount to sector peers (-69%), which may indicate undervaluation or specific company headwinds.
Return vs XLC: Since May 20, 2025, CMCSA has lost 30.4% against a loss of 1.7% for XLC.
Performance against XLC
CMCSA and the Communication Services sector fund over the same days.
Revenue and earnings
How much CMCSA sells, and how much of it becomes profit.
The quarterly bars end with Q2 '26 (the quarter to June 30, 2026); CMCSA reported again on October 22, 2026, and that quarter is not in our statement data yet. The 12-month figures come from the statistics feed and may include it.
Revenue growth: Revenue fell 0.0% in FY2025 to $124B, from $124B a year earlier.
Profit margin: The net margin was 15.9% in FY2025, up from 12.8% the year before.
Profitable: CMCSA earned $19.7B in FY2025.
Earnings reality check
Did CMCSA beat what analysts expected, and how did the stock react?
Earnings record: CMCSA beat the analyst estimate in 6 of the last 6 quarters.
Market reaction: The stock fell in the first session after 3 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Oct 22, 2026after close | $0.99 | $1.07 | +8.08% | -0.66% | -2.50% |
| Jul 23, 2026after close | $0.97 | $1.04 | +7.22% | +1.73% | +7.98% |
| Apr 23, 2026after close | $0.73 | $0.79 | +8.22% | -12.90% | -14.54% |
| Jan 29, 2026after close | $0.76 | $0.84 | +10.53% | +1.74% | +5.51% |
| Oct 30, 2025after close | $1.10 | $1.12 | +1.82% | +1.90% | -0.04% |
| Jul 31, 2025after close | $1.18 | $1.25 | +5.93% | -2.14% | -4.69% |
As of October 30, 2026, CMCSA has beaten the analyst EPS estimate in 6 of its last 6 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on October 22, 2026, came in 8.08% above the estimate and the stock moved -0.66% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
CMCSA AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 59.0, in neutral territory.RSI above 50 ›
An RSI of 59.0 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line below zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of CMCSA
The score, the reasoning behind it, and what could move the price next.
CMCSA is trading at $23.22, below both of its main moving averages. The price sits 0.76% below the 50-day average of $23.40 and 10.96% below the 200-day average of $26.08. Within its 52-week range, the price is at 22%, and it stands 13.38% above the 52-week low of $20.48.
Recent gains sit against a weaker record over longer spans. Over the past month the price rose 6.71%, but over the past three months it fell 3.09% and over the past year it fell 9.31%. In the last session the price rose 4.27% on volume that was 36.6% above its average. Momentum is neutral: the 14-day RSI stands at 59.0, in the neutral zone, and the MACD line is negative.
Rating reaffirmed ›
Evercore ISI Group kept its Outperform rating on October 23, 2026.
Source: Analyst action, Evercore ISI Group, October 23, 2026
Earnings beat, but the stock fell ›
The October 22, 2026 report beat the EPS estimate by 8.08%, and the share price fell 0.66% in the first session after it.
Source: Earnings report, October 22, 2026
- Keep an eye on the two closest levels: the 50-day SMA at $23.40 sits above the price, while the 20-day EMA at $22.17 sits below it.
- A 14-day RSI of 59.0, in the neutral zone, together with a negative MACD line describes the current momentum. Readings above 70 or below 30 would signal stretched momentum.
- CMCSA beat estimates in 6 of the last 6 reports, yet after the October 22, 2026 report the share price dropped 0.66% in the first session.
CMCSA remains in a downtrend while it trades below both its 50-day average of $23.40 and its 200-day average of $26.08. A close back above the 50-day average would be the first sign of a repair. That 50-day SMA at $23.40 is the first hurdle above the price.
To the downside, the first level under the price is the 20-day EMA at $22.17.
Technical indicators
Momentum and trend for CMCSA, from its daily closes.
As of October 30, 2026, with CMCSA at $23.22, its 14-day RSI is 59.0 (neutral territory), its 50-day simple moving average is $23.40 and its 200-day is $26.08.
Calculated by CleaRank on daily closes as of October 30, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What CMCSA moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 30, 2026, CMCSA's 1-year correlation of daily returns is +0.23 with S&P 500 (SPY), +0.11 with Nasdaq 100 (QQQ), -0.03 with Bitcoin (BTC) and -0.08 with gold (XAU).
CMCSA price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Fewer than half of analysts rate it a buy ›
9 of 27 analysts rate it a buy or strong buy, 14 a hold and 4 a sell.Median target above the price ›
The median 12-month target of $27.75 is 19.5% above the price.More buy ratings than three months ago ›
9 of 27 rate it a buy now, against 9 of 28 three months ago.
CMCSA Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 23, 2026 | Evercore ISI Group | Maintains | Outperform |
| Oct 23, 2026 | TD Cowen | Maintains | Buy |
| Oct 23, 2026 | Rosenblatt | Maintains | Buy |
| Oct 19, 2026 | Rosenblatt | Maintains | Buy |
| Oct 2, 2026 | Scotiabank | Maintains | Sector Perform |
| Sep 29, 2026 | Barclays | Maintains | Equal-Weight |
As of October 30, 2026, 27 Wall Street analysts cover CMCSA: 9 rate it a buy or strong buy, 14 a hold and 4 a sell or strong sell. Their 12-month price targets range from $17.00 to $42.00. The median CMCSA price target is $27.75, 19.5% above the price of $23.22.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
CMCSA trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CMCSA trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CMCSA's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CMCSA tends to move, against the market and on its own.
CMCSA price history and drawdowns
CMCSA's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
1/4Average daily move under 2% ›
The price has moved 1.85% on an average day (30-day standard deviation of daily returns).Not yet recovered from its worst fall ›
The worst fall was 55.6%, from September 2021 to October 2026; the price is still 50.7% below that peak.Most 1-year holds did not end higher ›
44% of 1-year holding periods in the last 10 years ended with a gain.Trailed the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $10,624, against $41,607 in the S&P 500 (SPY).
CMCSA Drawdowns & Recovery
As of October 30, 2026, CMCSA's worst peak-to-trough fall over the last 10 years with dividends reinvested was -55.6% (September 2021 to October 2026); it is still 50.7% below that peak, and 44% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CMCSA in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CMCSA trailed the S&P 500 over this period: $10,624 against $41,607.
A $10,000 investment in CMCSA in October 2016 would be worth about $10,624 today with dividends reinvested, compared with about $41,607 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CMCSA, and which have not.
Strongest month, November: an average of +4.73%, up in 6 of 10 years.
Weakest month, September: an average of -4.69%, up in 3 of 10 years.
This month, October: has averaged -2.41%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CMCSA's strongest calendar month has been November (average +4.73%, up in 6 of 10 years) and its weakest September (average -4.69%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
CMCSA stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CMCSA, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in CMCSA today could grow to about $10,769 by 2030 in the base case, with a 90th-percentile outcome near $21,649 and a 10th-percentile outcome around $5,357. The simulation models price only; at today's 5.68% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
CMCSA Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $25.01 for CMCSA by 2030 in the base case, from $23.22 today (1.1x over 4 years). The 10th-percentile path ends near $12.44. These are outcomes of a Monte Carlo simulation run on CMCSA's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $16.68 | $23.65 | $33.54 | |
| 2028 | $14.71 | $24.10 | $39.48 | |
| 2029 | $13.41 | $24.55 | $44.94 | |
| 2030 | $12.44 | $25.01 | $50.27 |
Method: a lognormal simulation of CMCSA's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
CMCSA insider trading
What the people running the company have bought and sold.
CMCSA insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought CMCSA shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 30, 2026, CMCSA insiders reported 3 open-market sales worth $2.3M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Brian L Roberts
Chief Executive Officer
|
Grant | 101.9K | - |
| Aug 17, 2026 | Edward D. Breen
Director
|
Grant | 62.4K | - |
| Jun 30, 2026 | Thomas J Baltimore Jr.
Director
|
Grant | 1.4K | - |
| Jun 30, 2026 | Louise F Brady
Director
|
Grant | 1.4K | - |
| Jun 30, 2026 | Edward D. Breen
Director
|
Grant | 815 | - |
| Jun 30, 2026 | Jeffrey A Honickman
Director
|
Grant | 1.8K | - |
| Jun 30, 2026 | Gordon A Smith
Director
|
Grant | 1.4K | - |
| May 19, 2026 | Brian L Roberts
Chief Executive Officer
|
Grant | 202.5K | - |
| Apr 2, 2026 | Daniel C Murdock
Officer
|
Grant | 5.3K | - |
| Mar 31, 2026 | Thomas J Baltimore Jr.
Director
|
Grant | 1.2K | - |
| Mar 31, 2026 | Louise F Brady
Director
|
Grant | 1.2K | - |
| Mar 31, 2026 | Edward D. Breen
Director
|
Grant | 697 | - |
| Mar 31, 2026 | Jeffrey A Honickman
Director
|
Grant | 1.5K | - |
| Mar 31, 2026 | Gordon A Smith
Director
|
Grant | 1.2K | - |
| Mar 17, 2026 | Jennifer Khoury
Officer
|
Option | 10.9K | $308.4K |
| Mar 5, 2026 | Jason S Armstrong
Chief Financial Officer
|
Sell | 4.5K | $142.6K |
| Mar 5, 2026 | Jason S Armstrong
Chief Financial Officer
|
Option | 73.5K | $2.1M |
| Feb 27, 2026 | Jason S Armstrong
Chief Financial Officer
|
Grant | 103.5K | - |
| Feb 27, 2026 | Michael J. Cavanagh
Chief Executive Officer
|
Grant | 35.0K | - |
| Feb 27, 2026 | Jennifer Khoury
Officer
|
Grant | 9.9K | - |
| Feb 27, 2026 | Daniel C Murdock
Officer
|
Grant | 13.4K | - |
| Feb 27, 2026 | Thomas J Reid
Officer
|
Grant | 93.1K | - |
| Feb 27, 2026 | Brian L Roberts
Chief Executive Officer
|
Grant | 45.6K | - |
| Feb 11, 2026 | Michael J. Cavanagh
Chief Executive Officer
|
Sell | 57.9K | $1.9M |
| Feb 11, 2026 | Michael J. Cavanagh
Chief Executive Officer
|
Option | 736.2K | $20.9M |
| Feb 11, 2026 | Brian L Roberts
Chief Executive Officer
|
Option | 984.3K | $27.9M |
| Feb 4, 2026 | Gordon A Smith
Director
|
Grant | 7.9K | - |
| Feb 3, 2026 | Asuka Nakahara
Director
|
Sell | 8.3K | $245.8K |
| Jan 20, 2026 | Jason S Armstrong
Chief Financial Officer
|
Grant | 8.2K | - |
| Jan 20, 2026 | Thomas J Baltimore Jr.
Director
|
Grant | 1.2K | - |
| Jan 20, 2026 | Madeline S Bell
Director
|
Grant | 5.1K | - |
| Jan 20, 2026 | Louise F Brady
Director
|
Grant | 1.2K | - |
| Jan 20, 2026 | Edward D. Breen
Director
|
Grant | 705 | - |
| Jan 20, 2026 | Jeffrey A Honickman
Director
|
Grant | 1.5K | - |
| Jan 20, 2026 | Daniel C Murdock
Officer
|
Grant | 1.6K | - |
| Jan 20, 2026 | Thomas J Reid
Officer
|
Grant | 12.3K | - |
| Nov 20, 2025 | Kenneth J Bacon
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Thomas J Baltimore Jr.
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Madeline S Bell
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Louise F Brady
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Edward D. Breen
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Jeffrey A Honickman
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Wonya Y. Lucas
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | Asuka Nakahara
Director
|
Grant | 9.0K | - |
| Nov 20, 2025 | David C Novak
Director
|
Grant | 9.0K | - |
| Nov 4, 2025 | Brian L Roberts
Chief Executive Officer
|
Grant | 1.7M | - |
| Sep 30, 2025 | Thomas J Baltimore Jr.
Director
|
Grant | 1.1K | - |
| Sep 30, 2025 | Louise F Brady
Director
|
Grant | 1.1K | - |
| Sep 30, 2025 | Edward D. Breen
Director
|
Grant | 637 | - |
| Sep 30, 2025 | Jeffrey A Honickman
Director
|
Grant | 1.4K | - |
| Sep 30, 2025 | David C Novak
Director
|
Grant | 1.1K | - |
| Jun 30, 2025 | Thomas J Baltimore Jr.
Director
|
Grant | 946 | - |
| Jun 30, 2025 | Louise F Brady
Director
|
Grant | 946 | - |
| Jun 30, 2025 | Edward D. Breen
Director
|
Grant | 561 | - |
| Jun 30, 2025 | Jeffrey A Honickman
Director
|
Grant | 1.2K | - |
| Jun 30, 2025 | David C Novak
Director
|
Grant | 946 | - |
| Jun 18, 2025 | Daniel C Murdock
Officer
|
Grant | 6.8K | - |
| Jun 5, 2025 | Jason S Armstrong
Chief Financial Officer
|
Grant | 9.5K | - |
| May 22, 2025 | Jennifer Khoury
Officer
|
Grant | 15.5K | - |
| May 6, 2025 | Michael J. Cavanagh
President
|
Grant | 171.0K | - |
Source: TwelveData, from SEC Form 4 filings
CMCSA stock forecast: questions people ask
Answered from the figures on this page, as of October 30, 2026.